Search

for
Search:

Learn

0 / 0 results

— no results

Research

5 / 28 results

research Objective Outcome Measures: Collecting Meaningful Data on Alopecia Areata

39 citations , November 2017 in “Journal of The American Academy of Dermatology”

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Effectiveness of Baricitinib for Nasal, Genital, and Beard Hair Regrowth in Patients with Severe Alopecia Areata: 12-Month Outcomes from a Prospective Observational Study

research Effectiveness of Baricitinib for Nasal, Genital, and Beard Hair Regrowth in Patients with Severe Alopecia Areata: 12-Month Outcomes from a Prospective Observational Study

November 2025 in “SKIN The Journal of Cutaneous Medicine”

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

research Gene Variant in Amish a Clue to Better Aging

January 2018 in “Genetic engineering & biotechnology news”

A genetic mutation linked to longer life and less disease was found in the Amish, and a drug is being developed to replicate these benefits.

research First-In-Human Clinical Trial Evaluating AI-09, A Novel Long-Lasting Ready-To-Use Liquid Injectable Neuromodulator For The Treatment Of Glabellar Lines

July 2025 in “Journal of Investigative Dermatology”

AI-09 is safe, effective, and reduces wrinkles for up to 6 months.

Improvement in Scalp Hair Appearance Following Treatment With a Non-Ablative Fractional Laser: A Retrospective Observational Study

research Improvement in Scalp Hair Appearance Following Treatment With a Non-Ablative Fractional Laser: A Retrospective Observational Study

July 2025 in “Lasers in Surgery and Medicine”

Non-ablative fractional laser treatment safely improves hair growth and scalp appearance.

View more "eirion" in research →

Community Join

5 / 18 results

community Eirion ET-02( RS 5441) managed to defeat rodents, finally

in Technology 67 upvotes 11 months ago

ET-02 (RS 5441) shows promising results for hair growth, performing better in humans than in mice. There is debate over the effectiveness compared to minoxidil, with some users wanting more detailed data.

community Eirion Therapeutics Announces Potential Breakthrough Treatment for Hair Loss Based on First-in-Man Clinical Trial Results

in Update 415 upvotes 11 months ago

ET-02, a new hair loss treatment, shows promising results with a 6-fold increase in hair count, potentially outperforming minoxidil by activating stem cells in hair follicles. Further trials are ongoing to confirm its efficacy and safety, with potential market release in the future.

community Why does Pelage PP405 receive so much attention, while Eirion ET-02 seems to be almost forgotten?

in Research/Science 29 upvotes 4 months ago

ET-02 is seen as promising for addressing hair loss and graying, but PP405 is more advanced in development and has better publicity. Some users plan to use both treatments alongside minoxidil and dutasteride.

community ET-02 Now Recruiting in Texas for Phase 1

in Research/Science 20 upvotes 1 year ago

Eirion Therapeutics is recruiting for phase 1 of ET-02 in Texas, which showed promising hair growth results in non-clinical studies. ET-02 demonstrated significantly more hair growth compared to Minoxidil.

community Upcoming New Treatments - Based on Phase

in Research/Science 47 upvotes 1 week ago

Several new hair loss treatments are in development, with Cosmo Breezula and Kintor KX826 being the furthest along, expected to be commercialized by 2027. Veradermics is the only treatment in pill form, while others like KX/GT/Breezula will be topical.

View more "eirion" in community →